Specific code 2015 ICD-9-CM Diagnosis Code V07.59
Use of other agents affecting estrogen receptors and estrogen levels
  • 2015
  • Billable Thru Sept 30/2015
  • Non-Billable On/After Oct 1/2015

  • ICD-9-CM V07.59 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, V07.59 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Convert to ICD-10-CM: V07.59 converts directly to:
  • 2015/16 ICD-10-CM Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels
Applies To
  • Use of:
    • estrogen receptor downregulators
    • fulvestrant (Faslodex)
    • gonadotropin-releasing hormone (GnRH) agonist
    • goserelin acetate (Zoladex)
    • leuprolide acetate (leuprorelin) (Lupron)
    • megestrol acetate (Megace)
ICD-9-CM Volume 2 Index entries containing back-references to V07.59:
  • Use of
    • agents affecting estrogen receptors and estrogen levels NEC V07.59
    • estrogen receptor downregulators V07.59
    • fulvestrant (Faslodex) V07.59
    • gonadotropin-releasing hormone (GnRH) agonist V07.59
    • goserelin acetate (Zoladex) V07.59
    • leuprolide acetate (leuprorelin) (Lupron) V07.59
    • megestrol acetate (Megace) V07.59
ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM V07.59 is one of thousands of ICD-9-CM codes used in healthcare. Although ICD-9-CM and CPT codes are largely numeric, they differ in that CPT codes describe medical procedures and services. Can't find a code? Start at the root of ICD-9-CM, check the 2015 ICD-9-CM Index or use the search engine at the top of this page to lookup any code.